Xiaoqian Yang Selected Research

1-calcium phosphate-uracil

1/2019

1-calcium phosphate-uracil inhibits intraperitoneal metastasis by suppressing FAK in epithelial ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoqian Yang Research Topics

Disease

9	Inflammation (Inflammations) 09/2022 - 01/2020
8	Neoplasms (Cancer) 07/2020 - 05/2014
7	Ovarian Neoplasms (Ovarian Cancer) 07/2020 - 02/2015
5	Ulcerative Colitis 01/2022 - 01/2019
5	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 05/2021 - 01/2017
4	Fibrosis (Cirrhosis) 11/2022 - 01/2019
3	Colitis 09/2022 - 01/2020
3	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2021 - 01/2020
3	Infections 01/2021 - 12/2018
3	Hyperlipidemias (Hyperlipidemia) 08/2019 - 05/2019
3	Osteosarcoma (Osteogenic Sarcoma) 04/2015 - 01/2015
2	Hypertension (High Blood Pressure) 11/2022 - 01/2022
2	Glomerulonephritis 09/2022 - 01/2022
2	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 01/2022
2	Pulmonary Arterial Hypertension 01/2022 - 01/2022
2	Chordoma 04/2015 - 05/2014
1	Xerophthalmia 11/2022
1	Xerostomia 11/2022
1	Carcinogenesis 09/2022
1	Rheumatoid Arthritis 09/2022
1	Dyspepsia (Indigestion) 09/2022
1	Liver Diseases (Liver Disease) 04/2022
1	Hepatitis B 04/2022
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2022
1	Pulmonary Hypertension 01/2022
1	Lupus Nephritis 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Hyperuricemia 01/2022
1	Disease Progression 10/2021
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2021
1	Hepatocellular Carcinoma (Hepatoma) 05/2021
1	End Stage Liver Disease 05/2021
1	Endometriosis 03/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2021
1	Coronary Disease (Coronary Heart Disease) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Diabetes Mellitus 01/2021
1	Dermatitis 01/2021
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2021

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 09/2022 - 01/2015
4	Pyrrolizidine AlkaloidsIBA 01/2021 - 01/2017
4	Pharmaceutical PreparationsIBA 01/2021 - 01/2018
4	Paclitaxel (Taxol)FDA LinkGeneric 10/2015 - 02/2015
3	LipidsIBA 11/2022 - 01/2015
3	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2022 - 01/2019
3	AlkaloidsIBA 05/2021 - 01/2020
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2015
3	CytokinesIBA 01/2021 - 01/2016
3	Therapeutic UsesIBA 03/2020 - 01/2016
2	InflammasomesIBA 09/2022 - 01/2022
2	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 01/2022
2	apremilastIBA 01/2022 - 01/2019
2	EnzymesIBA 01/2022 - 01/2021
2	Phosphodiesterase 4 InhibitorsIBA 01/2022 - 01/2020
2	beta-aminoarteether maleateIBA 10/2021 - 01/2016
2	Polysaccharides (Glycans)IBA 05/2021 - 01/2020
2	Imiquimod (Aldara)FDA LinkGeneric 01/2021 - 01/2020
2	Cisplatin (Platino)FDA LinkGeneric 07/2020 - 01/2020
2	BerberineIBA 03/2020 - 01/2020
2	isoquinolineIBA 03/2020 - 01/2020
2	CholesterolIBA 08/2019 - 08/2019
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2018 - 10/2015
2	(2- (4- methoxyphenyl)- 4- quinolinyl)(2- piperidinyl)methanolIBA 10/2015 - 04/2015
2	Hyaluronic Acid (Hyaluronan)IBA 06/2015 - 02/2015
2	Small Interfering RNA (siRNA)IBA 06/2015 - 02/2015
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2022
1	Cardiac GlycosidesIBA 09/2022
1	GlycosidesIBA 09/2022
1	Ficusin (Psoralen)IBA 04/2022
1	NucleosidesIBA 04/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022
1	Adenosine Monophosphate (AMP)IBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	NucleotidesIBA 01/2022
1	Uric Acid (Urate)IBA 01/2022
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 01/2022
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2022
1	Natriuretic PeptidesIBA 01/2022
1	Antiphospholipid AntibodiesIBA 10/2021
1	artemisinin (artemisinine)IBA 10/2021
1	LDL Receptors (LDL Receptor)IBA 05/2021
1	Proprotein Convertase 9IBA 05/2021
1	Sterol Regulatory Element Binding Protein 2IBA 05/2021
1	Alkaline PhosphataseIBA 05/2021
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 03/2021
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 03/2021
1	UbiquitinIBA 03/2021
1	HydrolasesIBA 02/2021
1	HomocysteineIBA 02/2021
1	methyl 4-(adenin-9-yl)-2-hydroxybutanoateIBA 02/2021
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2021
1	Antinuclear AntibodiesIBA 01/2021
1	LDL CholesterolIBA 01/2021
1	triptolideIBA 01/2021
1	Plant Growth Regulators (Plant Hormones)IBA 01/2021

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2018 - 02/2015
3	Therapeutics 10/2015 - 04/2015
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 09/2022